SIRT3 and metabolic dysfunction-associated steatotic liver disease: Sirt3 can activate BNIP3-dependent mitophagy via the ERK-CREB signaling pathway, protecting hepatocytes in non-alcoholic fatty liver disease (Li et al., 2018a).